United States Dementia Cases Estimated to Double by 2060
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
FDA Approved First Medication for Obstructive Sleep Apnea
On Dec. 20, 2024, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide) for the…
FDA updates Definition of “Healthy Foods” For Packaging, first time in three decades
On Dec. 19, 2024, the U.S. Food and Drug Administration announced it had updated the definition of “healthy…
tRNAs Help Some mRNAs Get Lost in Translation
On Nov. 21, 2024, teams at the University of Texas Southwestern Medical Center report a new way that…
nearly 260 million people in the U.S. predicted to have overweight or obesity by 2050
On Nov. 14, 2024, an analysis from the Global Burden of Disease Study Collaborator Network warned of an…
Cleveland Clinic Study Identified Key Factors That Can Impact Long-Term Weight Loss in Patients with Obesity Prescribed GLP-1 RA Medications
On Sep. 13, 2024, a Cleveland Clinic study was announced that identified key factors that can impact the…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
Novo Nordisk announced 4.1 billion USD investment to expand US manufacturing capacity
On Jun. 24, 2024, Novo Nordisk announced plans to invest 4.1 billion US dollars to build a second…
Wegovy received FDA approval for cardiovascular risk reduction in adults with known heart disease or obesity
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
Food allergy associated with lower risk of SARS-CoV-2 infection
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
Vibativ effectively helped treat secondary bacterial infections in COVID-19 patients
On Jun. 21, 2021, Cumberland Pharma released a series of case reports describing the effectiveness of Vibativ (telavancin)…
FDA approved new drug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
FDA approved Saxenda for the treatment of obesity in adolescents aged 12-17
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
Research confirmed obesity is a cause of kidney disease
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
NIH-funded study linked adolescent brain differences to increased waist circumference
On Oct. 13, 2020, the National Institute on Drug Abuse (NIDA) and nine other institutes, all part of…
USDA research showed higher carbohydrate and balanced fat intake can prevent certain diseases
On Sept. 15, 2020, a team of scientists in the U.S. Department of Agriculture’s (USDA) Agriculture Research Service…
Factors inherent to obesity could increase vulnerability to COVID-19
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
NIH awarded $95 million for Einstein-Mount Sinai Diabetes Research Center
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
FDA approved Novo Nordisk’s injection for obesity
On Dec. 23, 2014, Novo Nordisk the FDA approved a formulation of Novo Nordiskï¾’s diabetes drug, liraglutide, for…
Texas Biomed researchers published a genetic linkage map for the rhesus monkey
In 2006, Texas Biomed researchers published a genetic linkage map for the rhesus monkey. In 1999, Texas Biomed…
Stanford researchers discovered obestatin, a hormone that suppresses appetite
On Nov. 10, 2005, Stanford researchers announced they had discovered obestatin, a hormone that suppresses appetite. The discovery…
The National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer initiative
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
University of Alabama Mecial Center’s new multi-specialty clinic and College of Community Health Sciences opened
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…
An obesity working group is established by the Commissioner of Food and Drugs
On Oct. 8, 2003, an obesity working group was established by the Commissioner of Food and Drugs, charged…
Dr. Ute Hochgeswender at the OMRF and Dr. Miles Brennan from the Eleanor Roosevelt institute designed genetically engineered mice
On Aug. 30, 1999, Dr. Ute Hochgeswender, Development Biology Research Program from the Oklahoma Medical Research Foundation (OMRF)…
Texas Biomed researchers published the baboon gene map, the first genetic linkage of a nonhuman primate
In 1999, Texas Biomed researchers published the baboon gene map, the first genetic linkage of a nonhuman primate….
Diet drug fen-phen was taken off the market
On Sept. 15, 1997, Wyeth-Ayerst Laboratories and Interneuron Pharmaceuticals, manufacturers of the popular off-label obesity combination therapy known…